| Planned pregnancy in a chronic myeloid leukemia patient in molecular remission. | |
| | |
MedLine Citation:
|
PMID: 22928126 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Excellent response rates and a good quality of life have been observed since the introduction of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) treatment. Consequently, some challenges began to appear in CML women in child-bearing age wishing to become pregnant. Currently, many women around the world are in stable major/complete molecular response MMR/CMR (MMR: <0.1% BCR-ABL/ABL and CMR: undetectable BCR-ABL mRNA by RQ-PCR transcript levels on the international scale). The condition of stable MMR/CMR is linked to a long-term virtual absence of progression to the accelerated and blastic phase and to the possibility of stopping the TKI treatment with the maintenance of a condition of CMR in a proportion of cases. Imatinib teratogenic and prescribing information prohibits the use of it during pregnancy. We describe the case of a 36-year-old female patient with CML in chronic phase who stopped imatinib after 2 years in major molecular response (MMR) to plan a pregnancy. Molecular monitoring by RQ-PCR was performed quarterly. She achieved a safe pregnancy and delivery maintaining an optimal molecular response throughout the pregnancy. Isolated literature reports have been described, but no formal advice has been described at present time. |
| | |
Authors:
|
Carolina Pavlovsky; Isabel Giere; Germán Van Thillo |
Related Documents
:
|
9573366 - Differential expressions of mrna for proteoglycans, collagens and transforming growth f... 1036926 - The effect of rifamycin sv on the wound-healing process. 11315136 - Review of welfare concerns relating to commercial and special permit (scientific) whaling. 15846046 - 3-d ultrastructural distribution of collagen in human placental villi at term in relati... 16026276 - Antithrombin abnormalities and perinatal management. 17214446 - "all the rest is normal". a pilot study on the communication between physician and pati... |
Publication Detail:
|
Type: Journal Article Date: 2012-05-16 |
Journal Detail:
|
Title: Case reports in hematology Volume: 2012 ISSN: 2090-6579 ISO Abbreviation: Case Rep Hematol Publication Date: 2012 |
Date Detail:
|
Created Date: 2012-08-28 Completed Date: 2012-08-30 Revised Date: 2013-04-15 |
Medline Journal Info:
|
Nlm Unique ID: 101576456 Medline TA: Case Rep Hematol Country: United States |
Other Details:
|
Languages: eng Pagination: 624590 Citation Subset: - |
Affiliation:
|
FUNDALEU, Centro de Internación e Investigación Clínica Angélica Ocampo, Pte José E. Uriburu 1520, C1114AANP Buenos Aires, Argentina. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A paraneoplastic syndrome characterized by extremity swelling with associated inflammatory infiltrat...
Next Document: Paradoxical Immune Reconstitution Syndrome Presenting as Acute Respiratory Distress Syndrome in a Le...